Modeling the survival in patients with HIV by the presence of competing risks for death: sub-distribution and cause-specific hazard approach

[1] Alvarez-Uria G(2013)Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: Data from a cohort study in India PeerJ 1 e90-e90

[2] Andersen PK(2003)Generalised linear models for correlated pseudo-observations, with applications to multi-state models Biometrika 90 15-27

[3] Klein JP(2015)Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US Antiviral Therapy 20 21-28

[4] Rosthøj S(2014)State of art the competing risks survival analysis for cancer patients Transl Gastrointestinal Cancer 3 155-159

[5] Asghari Jafarabadi M(2015)Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study BMC Infect Dis 15 334-5369

[6] Pourhosseingholi MA(2007)A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards Stat Med 26 5360-611

[7] Hajizadeh E(2009)HIV-associated opportunistic infections—going, going, but not gone: the continued need for prevention and treatment guidelines Clin Infect Diss 48 609-e7

[8] Fatemi SR(2019)Cause-specific mortality among HIV-infected people in Ontario, 1995–2014: a population-based retrospective cohort study CMAJ Open 7 E1-509

[9] Ayele HT(2019)Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune Western India BMC Infect Dis 19 714-16

[10] van Mourik MS(2008)The infectiousness of tuberculosis patients coinfected with HIV PLoS Med 5 e188-174

[1] Alvarez-Uria G(2013)Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: Data from a cohort study in India PeerJ 1 e90-e90

[2] Andersen PK(2003)Generalised linear models for correlated pseudo-observations, with applications to multi-state models Biometrika 90 15-27

[3] Klein JP(2015)Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US Antiviral Therapy 20 21-28

[4] Rosthøj S(2014)State of art the competing risks survival analysis for cancer patients Transl Gastrointestinal Cancer 3 155-159

[5] Asghari Jafarabadi M(2015)Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study BMC Infect Dis 15 334-5369

[6] Pourhosseingholi MA(2007)A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards Stat Med 26 5360-611

[7] Hajizadeh E(2009)HIV-associated opportunistic infections—going, going, but not gone: the continued need for prevention and treatment guidelines Clin Infect Diss 48 609-e7

[8] Fatemi SR(2019)Cause-specific mortality among HIV-infected people in Ontario, 1995–2014: a population-based retrospective cohort study CMAJ Open 7 E1-509

[9] Ayele HT(2019)Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune Western India BMC Infect Dis 19 714-16

[10] van Mourik MS(2008)The infectiousness of tuberculosis patients coinfected with HIV PLoS Med 5 e188-174